FP7Reintegration grant2011–2015

ER AND METABOLISM · Oxidative protein folding and pathogenesis of metabolic disorders

FP7 — People (Marie Curie Actions)

Duration
2011-03-01 → 2015-02-28
EU contribution
€100,000
Participants
1
Scheme
MC-IRG

Lines connect the coordinator with its partners.

Results in brief

Periodic Report Summary - ER AND METABOLISM (Oxidative protein folding and pathogenesis of metabolic disorders)

The ability of secreted proteins to arrive at their correct three-dimensional structure is dependent on the formation of correctly placed disulfide bonds between cysteine residues. This reaction is termed oxidative protein folding, because it entails abstraction of electrons from the protein (two for every disulfide bond formed) and their donation to a terminal electron acceptor - usually molecular oxygen. This process is catalyzed by an enzymatic apparatus located in the lumen of the endoplasmic reticulum, an intracellular organelle charged with the handling of newly-synthesized proteins destined for secretion. In this project we examined the impact of interfering genetically with the function of the aforementioned enzymatic apparatus in live mice and in cells explanted from them. The objective was to gain insight into the functional significance of oxidative protein folding in a complex mammal and to explore the consequences of interfering with it. Genetically-modified mice with compound deficiency in the enzymes mediating disulfide bond formation were produced through the techniques of germline gene manipulation. Compound mutant mice deficient in Ero1l (encoding the dithiol oxidase ERO1a), Ero1lb (encoding the dithiol oxidase ERO1b) and Prdx4 (encoding an ER-localized peroxiredoxin) were produced and analyzed. Achievement: These mice are now available for the larger research community as research tool. Unexpectedly, we found that combined loss-of-function mutations in genes encoding the ER thiol oxidases ERO1a, ERO1b, and PRDX4 was NOT incompatible with cell survival. Achievement: This finding indicates that the process of disulfide bond formation in the secretory pathway is highly redundant and suggests broad latitudes for manipulating this parameter to therapeutic needs - should the utility of such manipulation be clarified by further research. Unexpectedly, combined loss-of-function mutations in genes encoding the ER thiol oxidases ERO1a, ERO1b, and PRDX4 compromised the extracellular matrix in mice and interfered with the intracellular maturation of procollagen. These severe abnormalities were associated with a 5-fold lower procollagen 4-hydroxy- proline content and enhanced cysteinyl sulfenic acid modification of ER proteins. Indicating a defect in the normal maturation of collagen, a major constituent of tissues. Ascorbic acid content was lower in mutant mice, and ascorbic acid supplementation improved procollagen maturation and lowered sulfenic acid content in vivo. In vitro, the presence of a sulfenic acid donor accelerated the oxidative inactivation of ascorbate by an H2O2-generating system. Achievement: This study indicates that compromised ER disulfide relay exposes protein thiols to competing oxidation to sulfenic acid, resulting in depletion of ascorbic acid, impaired procollagen proline 4-hydroxylation, and a noncanonical form of scurvy. Thus uncovering an unexpected link between oxidative protein folding and metabolism of an essential human nutrient.

Data: CORDIS, © European Union

Project objective

Endoplasmic reticulum (ER) oxidation 1 (ERO1) trasfers disulfide bonds to protein disulfide isomerase (PDI) and is essential for oxidative protein folding in simple eukaryotes such as yeast and worms. Higher eucaryotes have alternative pathways for disulfide bond formation (Zito et al., 2010). Recently we have discovered that the ER localized peroxiredoxin 4 (PRDX4) is able to couple use of hydroperoxides for oxidative protein folding, independently of ERO1 (Zito et al., 2010b). Hydrogen peroxide production is coupled both to nutrient assimilation and to insulin signaling whereas disulfide bond formation is limiting to the production of important signaling molecules such as insulin itself (in nutrient and insulin-responsive beta cells) and adipokines (in insulin responsive adipose tissue). The aim of this proposal is to evaluate, in cultured cells and intact mice, the impact of PRDX4 and ERO1 activity on the biosynthesis and the functional state of insulin and adypokines and consequently on intermediary metabolism. Recent evidence indicates that disulfide bond formation can be manipulated with chemical probes (Blais et al., 2010). Therefore the proposed study may bring to light novel targets for pharmacological intervention in diabetes and insulin resistance states.

Original text from CORDIS.

Participants

  • THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE · CAMBRIDGECoordinatorUnited Kingdom

Links

Data: CORDIS, © European Union